General Information
Revision date
2015-01-04
Product name
Irbesartan/Hydrochlorothiazide Tablets
1.2.1 Relevant identified uses
Pharmaceutical product
supplier name
Winthrop U.S A business of Sanofi U.S
Icons in SDS
Company Information
company name
Winthrop U.S A business of Sanofi U.S
Section 2
OSHA HCS Classification
Classification of the finished drug product is not required according to OSHA 29 CFR 1910.1200. The following information is provided for the drug substance, irbesartan:
2.1 Classification of the substance or mixture
Reproductive toxicity, Category 2 Effects on or via lactation Specific target organ toxicity - repeated exposure, Category 2 Hydrochlorothiazide is not classified as a hazardous substance. 2.2 Label elements in accordance with 29 CFR 1910.1200 Labeling of the finished drug product is not required according to OSHA 29 CFR 1910.1200. The following information is provided for the drug substance, irbesartan:
Hazard statements
Suspected of damaging fertility or the unborn child. May cause harm to breast-fed children. May cause damage to kidneys through prolonged or repeated exposure if swallowed.
Hazard pictograms
Health hazard
Prevention
Obtain special instructions before use. Avoid contact during pregnancy/while nursing. Do not handle until all safety precautions have been read and understood. Wear protective gloves. Do not breathe dust. Wash hands thoroughly after handling. Do not eat, drink or smoke while using this product.
Response
If exposed or concerned Get medical attention
Storage
Store locked up
Disposal
Dispose of in accordance with applicable regional, national and local laws and regulations.
2.3 Other hazards
Not classified.